SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-053536
Filing Date
2023-10-16
Accepted
2023-10-16 16:15:09
Documents
12
Period of Report
2023-10-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20231012.htm   iXBRL 8-K 54518
  Complete submission text file 0000950170-23-053536.txt   167328

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20231012.xsd EX-101.SCH 2465
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20231012_pre.xml EX-101.PRE 10193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20231012_lab.xml EX-101.LAB 12409
6 EXTRACTED XBRL INSTANCE DOCUMENT gls-20231012_htm.xml XML 4357
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 231327483
SIC: 2834 Pharmaceutical Preparations